Wuxi Biologics
TOPIC
 / company

Wuxi Biologics

Wuxi Biologics
Wuxi Biologics
Wuxi Biologics is a pharmaceutical research and services company based in Wuxi, Jiangsu province. It counts 16 of the world's top 20 drug makers as customers and 28 of China's 50 largest medicine producers. The company supplied ingredients for AstraZeneca's Covid-19 vaccine. It is one of six businesses founded by its chairman Ge Li, along with Wuxi Apptec.
Chairman / President
Li Ge
CEO / Managing Director
Chen Zhisheng
CFO / Finance Director
Tu Ming
Industry
Biopharmaceutical
Website
wuxibiologics.com.cn
Headquarters address
No. 108 Mashan Meiliang Road, Binhu Distroct, Wuxi City, Jiangsu Province, China
Stock Code
SEHK:2269
Year founded
2010
LATEST China Science NEWS

WHO responds to agency chief’s alleged pledge to ‘strengthen ties’ with Taiwan

Japanese Finance Minister Satsuki Katayama claims the WHO chief said he wanted to cultivate closer ties with Taiwan. Photo: AFP

Should Opec worry? China joins US shale oil revolution with new fracking tech

4
China has the largest recoverable shale gas and third largest recoverable shale oil reserves in the world, according to the US Energy Information Administration. Photo: Xinhua

Former Nasa chief calls for new US approach to moon landing – much like China’s

videocam
65
A former Nasa chief told Congress that the Artemis III mission and those beyond should be cancelled and the US “should start over”. Photo: TNS

Over 10 years in the making: China launches 2,000km-wide AI computing hub

videocam
11
Chinese scientists say their innovation means computing centres separated by distance but linked by optical network could work together almost as efficiently as a single giant computer. Image: Shutterstock

How China pulled off a critical mineral tech revolution in just 10 months

4
Illustration: Lau Ka-kuen
MORE China Science NEWS
Chinese biotech firms set to crack the global market within a decade, according to industry experts. Photo: Getty Images
China manufacturing

China’s biotech firms may see ‘major breakthroughs’ within a decade. Here’s why

Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.

videocam
Shanghai

China bets on bio-manufacturing as new growth engine, bid for tech self-reliance

Hong Kong stock market

Ignore China’s innovation boom ‘at your own peril’, General Atlantic CEO warns

Hong Kong stock market

Hong Kong stocks post longest decline in 9 months on renewed US-China tensions

Markets react to Trump’s threat to impose a 100 per cent tariff on all Chinese imports and restrict critical software exports from November.

The Hang Seng Index is headed for its steepest decline since a 13 per cent plunge on April 7. Photo: Jelly Tse
Biomedicine: Geopolitics

Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms

Chinese drug makers have ‘minimal sales exposure to the US’, Jefferies analysts say.

Hong Kong stock market

Hong Kong stocks cap weekly decline on valuation, tariff jitters

‘Gravity has reasserted itself’ and the global US$15 trillion rebound this year ‘now feels stretched’, investor says.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Chinese biotechs get a shot in the arm from policy support, licensing deals

‘We are on an upcycle in the industry and sentiment is very strong,’ Xufunds Investment fund manager Wang Chen says.

Shares of WuXi Biologics have more than doubled year to date. Photo: Shutterstock
Biomedicine: Companies

Chinese biotech firm MGI’s DNA sequencers gaining in the market, BGI CEO says

MGI’s latest product, the DNBSEQ-T7+, can sequence 144 human genomes a day, or one every 10 minutes.

Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

Hong Kong stock market

Alibaba surge leads Hong Kong stocks to biggest gain in 2 weeks

Hong Kong stocks are undervalued, and a ‘liquidity friendly environment’ is set to propel them higher, analyst says.

Exchange Square in Central, Hong Kong, home of the city’s bourse operator, is pictured on May 20, 2025. Photo: Xinhua
Hong Kong stock market

Hong Kong stocks rebound on US-China trade talk optimism

Hang Seng Index recovers from an intraday loss of as much as 0.9 per cent, snapping a four-day losing streak.

People walk past an electronic board showing the Hang Seng Index in Hong Kong. Photo: Zuma Press Wire/dpa
Hong Kong stock market

Hong Kong stocks sustain 3-year-high level on trade optimism

A US deal with Japan and scheduled talks with China reduce concerns about damage to the global economy from trade conflicts.

Hong Kong stock market

Hong Kong stocks cap weekly gain on earnings optimism

Wuxi AppTec jumps after it says its first-half profit likely more than doubled from a year earlier.

Hong Kong stock market

Hong Kong stocks gyrate amid Iran conflict after US strike, Hormuz threat

Oil futures surge after US President Donald Trump says attacks ‘obliterated’ targets and Iran threatens to close key oil shipping route.

Oil tankers pass through the Strait of Hormuz in a 2018 file photo. Photo: Reuters
Hong Kong stock market

Hong Kong stocks rise on China policy hopes after soft economic data

China’s industrial output and fixed-asset investment fell short in May, and the downturn in the property market deepened.

Workers pack knives at a factory in Yangjiang, south China’s Guangdong province, on June 11, 2025. Photo: Xinhua
Hong Kong stock market

Hong Kong stocks erase gains amid ongoing US-China trade talks

Investors appear to look more cautiously at ongoing US-China trade talks in London.

Hong Kong stock market

Hong Kong stocks jump as US blocks Trump’s tariffs in win for global trade

Hang Seng Index approached a two-month high on bets global trade relations and market sentiment will improve.

videocam
Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks gain on earnings boost as Meituan beats market consensus

Gains limited by losses in leading carmakers amid lingering concerns about a prolonged price war.

videocam
Exchange Square in Central. Hong Kong. Photo: Sam Tsang
Biomedicine: Companies

Big Chinese pharma can beat Trump’s policies with cost efficiencies: analysts

Trump seeks to slash domestic drug prices, bring back pharmaceutical manufacturing to the US and slap tariffs on imports.

videocam
China Future Tech briefing

Biomedicine | China’s biomedical sector braces for headwinds

The coast isn’t entirely clear for the world’s second-largest biomedical sector, which faces possible tariff increases and US import curbs.

Biomedicine: Companies

China’s WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation explicitly names WuXi.

WuXi Biologics company logo. Photo: Shutterstock
Biomedicine: Companies

WuXi AppTec, WuXi Biologics surge on slimmer chances of Biosecure Act’s passage

The bill’s absence from the proposed amendments to the US National Defence Authorisation Act comes as a reprieve for the two biotech firms.

WuXi AppTec says it provides US lawmakers and federal agencies with information about the services it provides to customers in the US and around the world. Photo: Shutterstock
Biomedicine: Policy

Shanghai to back local biopharma firms’ overseas push, regulatory compliance

The initiative aims to generate about US$7 billion from medical product exports by 2027.

videocam
Wuxi AppTec

WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened US scrutiny.

US-China relations

Senior US official lauds China cooperation on tech-transfer controls

‘End-use checks’ have improved since the pandemic, but pending congressional legislation is keeping mainland firms in limbo.

videocam
6
Matthew Axelrod (right), US assistant secretary for export enforcement at the Department of Commerce, speaks at the Centre for Strategic and International Studies in Washington on Thursday, with William Reinsch of CSIS.
US-China relations

‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs

Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.

videocam
19
Various pieces of US legislation intended to blunt China’s influence and competitive edge are soon due for consideration in Washington. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks surrender rally as WuXi Bio slumps 21% while Tencent, Li Auto gain

Stocks declined, capping another week of losses, after WuXi Biologics suffered another major plunge. Market surrendered an earlier rally fuelled by favourable Beijing policy and robust EV deliveries in January.

13
Hong Kong stock market

Hong Kong stocks rebound as WuXi Bio, Sands get support to stem market rout

Stocks rebound from a 13-month low, snapping a three-day slump. Some companies are quickly pushing for buy-backs to help stem losses and shore up market confidence.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement